688331 榮昌生物
按盤價 
123.580 +6.760 (+5.787%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 25.367 | -54.148 | -35.907 | -23.706 | 7.847 |
| 總資產報酬率 ROA (%) | 11.135 | -26.633 | -26.170 | -19.623 | 6.675 |
| 投入資產回報率 ROIC (%) | 13.140 | -31.295 | -30.278 | -22.301 | 7.336 | 邊際利潤分析 |
| 銷售毛利率 (%) | 87.280 | 80.362 | 77.432 | 64.766 | 95.175 |
| 營業利潤率 (%) | 22.227 | -84.786 | -138.651 | -128.900 | 21.245 |
| 息稅前利潤/營業總收入 (%) | 23.845 | -81.479 | -140.043 | -138.154 | 18.503 |
| 淨利潤/營業總收入 (%) | 21.828 | -85.526 | -139.547 | -129.364 | 19.368 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 8.708 | 102.862 | 102.567 | 112.858 | 63.826 |
| 價值變動淨收益/利潤總額(%) | 89.566 | 0.188 | -0.462 | -1.212 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -1.718 | 0.865 | 0.642 | 0.359 | -9.692 | 償債能力分析 |
| 流動比率 (X) | 1.429 | 1.051 | 1.976 | 3.663 | 3.758 |
| 速動比率 (X) | 1.191 | 0.748 | 1.318 | 3.067 | 3.300 |
| 資產負債率 (%) | 50.210 | 63.878 | 37.823 | 17.287 | 17.138 |
| 帶息債務/全部投入資本 (%) | 39.288 | 54.412 | 24.653 | 2.168 | 4.113 |
| 股東權益/帶息債務 (%) | 149.570 | 78.335 | 295.139 | 4,368.385 | 2,265.230 |
| 股東權益/負債合計 (%) | 99.164 | 56.550 | 164.386 | 478.465 | 483.513 |
| 利息保障倍數 (X) | 11.958 | -20.133 | 282.448 | 15.718 | -21.383 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 44.635 | 71.405 | 83.057 | 47.638 | 0.583 |
| 存貨周轉天數 (天) | 574.923 | 747.907 | 931.109 | 531.299 | 906.380 |
| 備註： | 即時報價更新時間為 27/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
